The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Alphabet Inc Class C | Common | 02079K107 | 725 | 5,500 | SH | DFND | 0 | 0 | 0 | |||
| Coherus Biosciences Inc | Bond | 19249HAB9 | 11,025 | 18,000,000 | PRN | DFND | 0 | 0 | 0 | |||
| Coherus Biosciences Inc | Common | 19249H103 | 187 | 50,000 | SH | DFND | 0 | 0 | 0 | |||
| Crown Castle Intl | Common | 22822V101 | 1,104 | 12,000 | SH | DFND | 0 | 0 | 0 | |||
| Coherus Biosciences Inc | Bond | 30050BAD3 | 3,668 | 3,434,000 | PRN | DFND | 0 | 0 | 0 | |||
| General Dynamics Corp | Common | 369550108 | 265 | 1,200 | SH | DFND | 0 | 0 | 0 | |||
| Goldman Sachs Physical Gold | Common | 38150K103 | 3,374 | 184,254 | SH | DFND | 0 | 0 | 0 | |||
| Humana Inc | Common | 444859102 | 1,654 | 3,400 | SH | DFND | 0 | 0 | 0 | |||
| Johnson & Johnson Inc | Common | 464285204 | 980 | 28,000 | SH | DFND | 0 | 0 | 0 | |||
| Matinas Biopharma Holdings Inc | Common | 478160104 | 312 | 2,000 | SH | DFND | 0 | 0 | 0 | |||
| Humana Inc | Common | 30303M102 | 2,402 | 8,000 | SH | DFND | 0 | 0 | 0 | |||
| Sprott Physical Gold Trust | ETF | 85207H104 | 3,788 | 264,500 | SH | DFND | 0 | 0 | 0 | |||